Helper-Dependent Adenoviral Vector-Mediated Gene Transfer in Aged Rat Brain
- 20 January 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (2) , 181-191
- https://doi.org/10.1089/104303401750061249
Abstract
Transfer of the neurotrophin gene into brain can attenuate age-related deficits such as neuronal atrophy and memory loss, but a suitable vector for this procedure has been lacking. The toxicity and immunogenicity of first-generation adenoviral vectors with E1 deletion (fgAdv) prohibit the application of gene transfer in the majority of central nervous system disorders. Here, we report less toxic and persistent gene expression mediated by helper-dependent adenovirus (hdAdv) in aged rat brain. After intrahippocampal or intraventricular inoculation of the vector, transgene expression was monitored by X-Gal staining and compared with fgAdv-mediated expression. Host inflammatory and immune responses against these vectors were evaluated by immunohistochemical detection of microglia, astrocytes, and infiltrating macrophages, as well as by enzyme-linked immunosorbent assay of cytokines TNF-α and IL-1β. Transgene expression mediated by hdAdv persisted for more than 183 days regardless of inoculation site, as compared with 33 and 66 days for fgAdv-mediated expression after intraventricular and intrahippocampal inoculation, respectively. Inoculation with hdAdv was also associated with reduced numbers of activated microglial cells, astrocytes, and infiltrating macrophages in brain tissue. Secretion of the proinflammatory cytokines TNF-α and IL-1β was minimal after hdAdv but not after fgAdv inoculation. These findings indicate that hdAdv would provide a safe and effective means to transfer therapeutic genes into aged brain.This publication has 48 references indexed in Scilit:
- Prolonged Transgene Expression Mediated by a Helper-Dependent Adenoviral Vector (hdAd) in the Central Nervous SystemMolecular Therapy, 2000
- Gene therapy in the CNSGene Therapy, 2000
- Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral VectorsExperimental Neurology, 1999
- Adenoviral vectors: prospects for gene delivery to the central nervous systemGene Therapy, 1999
- Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and primingGene Therapy, 1999
- Efficient Transfer of Genes into Senescent Cells by Adenovirus Vectors via Highly Expressed αvβ5 IntegrinBiochemical and Biophysical Research Communications, 1997
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- Microglia: a sensor to threats in the nervous system?Research in Virology, 1996
- Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrainNeuron, 1995
- Microglia: Intrinsic immuneffector cell of the brainBrain Research Reviews, 1995